The Effect of a Navigator Nurse- Supported Mobile Application Developed Based on the IMB Model on the Quality of Life of Patients With Celiac Disease
Key facts
- Who runs it
- Ankara Yildirim Beyazıt University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 1 Aug 2025
- Ended
- 1 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- IMB navigator app
- Record updated
- 17 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age ≥18 years
- Newly diagnosed with celiac disease
- Owning a smartphone and able to use the application
- Able to speak and understand Turkish
- Voluntary participation (informed consent)
Who cannot take part
- Severe gluten hypersensitivity
- Failure to meet inclusion criteria
- Withdrawal of consent during the study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial aims to evaluate the effect of a navigator nurse-supported mobile application, developed based on the Information-Motivation-Behavioral Skills (IMB) model, on the quality of life of adult patients newly diagnosed with celiac disease. Participants will be randomized into intervention and control groups. The intervention group will use the mobile application with navigator nurse support for six months, while the control group will receive routine clinical education. Outcomes will be assessed through validated questionnaires and clinical data.
The 2 groups in the trial
- Experimental: Navigator nurse-supported mobile application (IMB Model)Treatment being tested
Participants receiving the navigator nurse-supported mobile application based on the IMB model.
Treatment: IMB navigator app
- Control: Standard care without mobile applicationNo study treatment, for comparison
Participants receiving standard care without the mobile application.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 17 July 2026